Ocular implant containing a tyrosine kinase inhibitor
MYPI2025001820A0Undetermined Publication Date: 2021-09-25OCULAR THERAPEUTIX INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025001820
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-02-11
- Filing Date
- 2021-03-24
- Publication Date
- 2021-09-25
Abstract
The invention relates to a sustained release biodegradable ocular implant containing a tyrosine kinase inhibitor dispersed in a hydrogel for the treatment of a retinal disease for an extended period of time. (Figure 1)
Need to check novelty before this filing date? Find Prior Art
